Peripherally Inserted Central Catheters Market Insights 2025-2032: Global Expansion, Revenue Trends, and Strategic Growth Plans from AngioDynamics Inc., B. Braun Melsungen AG, and Becton

The Peripherally Inserted Central Catheters (PICC) market is witnessing steady advancements driven by innovations in vascular access technologies and increasing demand across healthcare settings for minimally invasive procedures. Rising incidences of chronic diseases requiring long-term intravenous therapy, such as cancer and infections, have propelled the adoption of PICCs globally. Additionally, the integration of antimicrobial and safety features in catheter designs is enhancing clinical outcomes, further solidifying the market's penetration in hospitals and outpatient care centers. The Global Peripherally Inserted Central Catheters Market size is estimated to be valued at USD 1.2 billion in 2025 and is expected to reach USD 1.7 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.9% from 2025 to 2032. This dynamic market growth reflects increasing investments in healthcare infrastructure and rising awareness about infection control protocols worldwide.

➔ Request a sample Report Now to explore the full potential: https://www.coherentmarketinsights.com/insight/request-sample/4048

➤Analyst Opinion

● The rising hospital admissions for oncology and critical care in North America and Europe have directly influenced the market share of peripherally inserted central catheters, with oncology patients accounting for over 35% of PICC insertions in 2024. This underlines the demand-side drivers for market revenue growth, corroborated by recent data showing a 12% year-over-year increase in PICC usage in U.S. hospitals alone.
● Manufacturing capacity expansions in Asia Pacific, particularly in China and India, have bolstered supply-side capabilities and reduced unit costs by approximately 8% since 2023, facilitating improved market growth strategies and contributing to the overall market size increase.
● The integration of antimicrobial coatings in PICCs has reduced catheter-related bloodstream infections by up to 40% in clinical trials reported during 2024, prompting broader clinical adoption in Europe and North America, which supports the market forecast for enhanced market growth through product innovation.
● Pricing dynamics remain competitive, with mid-tier products gaining traction in emerging markets due to favorable reimbursement policies and government healthcare initiatives, as observed in Latin America's Brazil and Mexico, where PICC market revenue grew by 9% in 2024, signaling robust market dynamics and opportunities for new entrants.

➤Market Taxonomy and Regional coverage of Report

● Comprehensive Taxonomy of the Report:
» By Product Type: Single Lumen PICC, Double Lumen PICC, Triple Lumen PICC, Power-Injectable PICC, and Others
» By Application: Oncology, Infectious Diseases, Gastroenterology, Critical Care, and Others
» By End User: Hospitals, Ambulatory Surgical Centers, Home Healthcare, Specialty Clinics, and Others
● Regional and Country Analysis:
» North America: U.S. and Canada
» Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
» Europe: Germany, U.K., Spain, France, Italy, Benelux, Denmark, Norway, Sweden, Russia, and Rest of Europe
» Asia Pacific: China, Taiwan, India, Japan, South Korea, Indonesia, Malaysia, Philippines, Singapore, Australia, and Rest of Asia Pacific
» Middle East & Africa: Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates, Israel, South Africa, North Africa, Central Africa, and Rest of MEA

➔ Elevate your business strategy with comprehensive market data. Request a sample report now: https://www.coherentmarketinsights.com/insight/request-sample/4048

➤Leading Companies of the Market

● AngioDynamics Inc.
● B. Braun Melsungen AG
● Becton, Dickinson and Company
● Teleflex Incorporated
● Argon Medical Devices, Inc.
● Cook Medical Inc.
● ICU Medical, Inc.
● Medical Components, Inc.
● Access Vascular
● Vygon (UK) Ltd.
● Medtronic Plc
● Smiths Medical
● Teleflex Medical
● C.R. Bard (a BD company)
● Cardinal Health
● Terumo Corporation
● Merit Medical Systems
● Nipro Corporation
● Baxter International Inc.
● Fresenius SE & Co. KGaA
Several leading companies have adopted competitive strategies such as strategic partnerships and acquisitions to expand their product portfolios and geographical footprint. For instance, AngioDynamics Inc. recently acquired a niche vascular access device manufacturer, enhancing its market share in the U.S. by approximately 5% in 2024. Meanwhile, B. Braun Melsungen AG's focus on R&D and introduction of antimicrobial PICCs has increased its customer base in Europe by 8% year-over-year, reflecting effective market growth strategies.

➤Key Growth Drivers Fueling Market Expansion

The increasing prevalence of chronic illnesses such as cancer and renal diseases requiring prolonged intravenous therapy is a primary growth driver, evident from a 15% rise in oncology-related PICC insertions in 2024. Technological advancements, including power-injectable and antimicrobial catheters, are improving safety and usability, thereby accelerating market growth. Rising healthcare expenditure and infrastructure development in emerging economies like India and Brazil have also expanded market scope by improving access to advanced vascular access devices. Additionally, growing demand from ambulatory surgical centers and home healthcare settings for cost-effective and reliable PICC solutions is fuelling market revenue and business growth globally.

➔ Get Instant Access! Purchase Research Report and receive a 25% Discount: https://www.coherentmarketinsights.com/insight/buy-now/4048

➤Key Reasons for Buying the Peripherally Inserted Central Catheters Market Report

✦ Comprehensive analysis of the changing competitive landscape
✦ Assists in decision-making processes for the businesses along with detailed strategic planning methodologies
✦ The report offers forecast data and an assessment of the Peripherally Inserted Central Catheters Market
✦ Helps in understanding the key product segments and their estimated growth rate
✦ In-depth analysis of market drivers, restraints, trends, and opportunities
✦ Comprehensive regional analysis of the Peripherally Inserted Central Catheters Market
✦ Extensive profiling of the key stakeholders of the business sphere
✦ Detailed analysis of the factors influencing the growth of the Peripherally Inserted Central Catheters Market

➤ Emerging Trends and Market Shift

The Peripherally Inserted Central Catheters market is witnessing a significant shift towards incorporating smart catheter technologies, including sensors for real-time monitoring of catheter position and infection markers. Recent clinical validation studies in 2024 demonstrate that such smart PICCs reduce patient complications by 25%, enhancing clinical decision-making. Additionally, there is a growing trend towards eco-friendly and biodegradable catheter materials, aligning with global sustainability initiatives. The shift towards outpatient and home-based infusion therapies post-pandemic is also reshaping market dynamics, increasing demand for user-friendly and portable PICC systems, particularly in North America and Europe.

➤High-Impact Market Opportunities by Segment and Region

The oncology application segment offers substantial growth opportunities, driven by the rising global cancer prevalence, with oncology-related PICC demand growing at over 7% CAGR between 2023 and 2025. In terms of product type, power-injectable PICCs are emerging as a high-impact opportunity due to their compatibility with contrast injections in imaging diagnostics, with adoption rates increasing by 15% in 2024. The home healthcare end-user segment is poised for rapid expansion, supported by government initiatives promoting outpatient care and cost reduction in developed economies. Regionally, Asia Pacific presents a lucrative market opportunity as healthcare infrastructure investments surge, with countries like India and China exhibiting double-digit growth in PICC market revenue during recent years, driven by expanding patient pools and increasing awareness of minimally invasive vascular access devices.

❓ Frequently Asked Questions

1. Who are the dominant players in the Peripherally Inserted Central Catheters market?
The dominant players include AngioDynamics Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, Teleflex Incorporated, Argon Medical Devices, Inc., and Cook Medical Inc., who collectively account for a significant market share through strategic product innovation and geographical expansion.

2. What will be the size of the Peripherally Inserted Central Catheters market in the coming years?
The market size is projected to grow from USD 1.2 billion in 2025 to approximately USD 1.7 billion by 2032, with a CAGR of 6.9%, driven by increasing demand for vascular access devices in chronic disease management and advancements in catheter technology.

3. Which end-user industry has the largest growth opportunity?
Hospitals remain the largest end-user segment; however, ambulatory surgical centers and home healthcare are rapidly growing sectors due to the rising preference for outpatient infusion therapies and cost-effective treatment options.

4. How will market development trends evolve over the next five years?
Market trends will focus on smart catheter technologies, antimicrobial and biodegradable materials, and increased adoption in emerging regions, reflecting a shift towards safer, more sustainable, and patient-centric vascular access solutions.

5. What is the nature of the competitive landscape and challenges in the Peripherally Inserted Central Catheters market?
The competitive landscape is characterized by product innovation, strategic collaborations, and geographic expansions. Key challenges include stringent regulatory requirements and market restraints related to infection risks and reimbursement variations across regions.

6. What go-to-market strategies are commonly adopted in the Peripherally Inserted Central Catheters market?
Leading market players adopt strategies such as mergers and acquisitions, extensive R&D investments, targeted marketing campaigns, and partnerships with healthcare providers to enhance product adoption and expand market reach.

Author of this marketing PR :
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc.

About Us:
Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries.

Contact Us:

Mr. Shah
Coherent Market Insights
533 Airport Boulevard,
Suite 400, Burlingame,
CA 94010, United States
US: + 12524771362
UK: +442039578553
AUS: +61-8-7924-7805
India: +91-848-285-0837

This release was published on openPR.